Matches in Nanopublications for { ?s ?p "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- NP482858.RAhT6MybBAi54XKQwBydFqDnaLwr9E5YAUD7-QMkRohJU130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482858.RAhT6MybBAi54XKQwBydFqDnaLwr9E5YAUD7-QMkRohJU130_provenance.
- NP586009.RApqnMk5h-XvwZYmEO1mKqYm7V9TPbhreiKmftJnrCfdg130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586009.RApqnMk5h-XvwZYmEO1mKqYm7V9TPbhreiKmftJnrCfdg130_provenance.
- NP802111.RAZ_hnRUblR5Yub_j720B-WyyKEw0EOl0BPZb0liRzI6w130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802111.RAZ_hnRUblR5Yub_j720B-WyyKEw0EOl0BPZb0liRzI6w130_provenance.
- NP843526.RAcAR_aGx5w35dYjCXMpL33p0loMy72bRWCFfg8aJA1ts130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843526.RAcAR_aGx5w35dYjCXMpL33p0loMy72bRWCFfg8aJA1ts130_provenance.
- NP848956.RAW6VsPaEEIvQqmLX2licKemSdNdyaLjWCfNyBPy9v-wY130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848956.RAW6VsPaEEIvQqmLX2licKemSdNdyaLjWCfNyBPy9v-wY130_provenance.
- NP952663.RAAmYocP8DQsPVOa8safUYW5d_505_2WNcil4s8ZwiTAM130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952663.RAAmYocP8DQsPVOa8safUYW5d_505_2WNcil4s8ZwiTAM130_provenance.
- NP515195.RALueaATd2TaTt8HQvDPaKha8RoNtw1C-bPWyglw3DqGk130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515195.RALueaATd2TaTt8HQvDPaKha8RoNtw1C-bPWyglw3DqGk130_provenance.
- NP648405.RAOYYFS6nqKzM4R4mOxfx_GJRWU50MaPBB8JNVLtNtnDY130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648405.RAOYYFS6nqKzM4R4mOxfx_GJRWU50MaPBB8JNVLtNtnDY130_provenance.
- NP491284.RABdi9DU-C48tZ8DExsbtqZhLU-PnYZx5dQpL2b_xy1Rg130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491284.RABdi9DU-C48tZ8DExsbtqZhLU-PnYZx5dQpL2b_xy1Rg130_provenance.
- NP808059.RALdtpyu3ZqgJ5NILRrewcPfF9x75qCHYCsPwAO74Fmck130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808059.RALdtpyu3ZqgJ5NILRrewcPfF9x75qCHYCsPwAO74Fmck130_provenance.
- NP755569.RAWiMmUG22r2h4RhFo9cNii0LhT4zMz1h87shNqzGeCMM130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755569.RAWiMmUG22r2h4RhFo9cNii0LhT4zMz1h87shNqzGeCMM130_provenance.
- NP755594.RA7wPDUjK1kJGwv7AlRA8PPoKaJHaa6ZC8D6xTAwgWpTg130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755594.RA7wPDUjK1kJGwv7AlRA8PPoKaJHaa6ZC8D6xTAwgWpTg130_provenance.
- NP952640.RAw_9un8yz1jPk_1l6RijYPjUfKuB6p9hfIL7wyWqi6wI130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952640.RAw_9un8yz1jPk_1l6RijYPjUfKuB6p9hfIL7wyWqi6wI130_provenance.
- NP952641.RA5A_Od9i6bEqGR8azYgLM_xEpNhPm_wsma4KpO3_2NzI130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952641.RA5A_Od9i6bEqGR8azYgLM_xEpNhPm_wsma4KpO3_2NzI130_provenance.
- NP476174.RAxcAmfMcBqrxIKWKgN5JgBJjz6GA_D9tVHQDd5Llo3Fg130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476174.RAxcAmfMcBqrxIKWKgN5JgBJjz6GA_D9tVHQDd5Llo3Fg130_provenance.
- NP476175.RAygcatjsiu4jaMgEbRAhwU2VdXYO4oD72TpfBm_JNle4130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476175.RAygcatjsiu4jaMgEbRAhwU2VdXYO4oD72TpfBm_JNle4130_provenance.
- NP476169.RAe-WP2DlHXUvJFx1ZddlIhOnHJTEnkgDPygooxkYYBBk130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476169.RAe-WP2DlHXUvJFx1ZddlIhOnHJTEnkgDPygooxkYYBBk130_provenance.
- NP755570.RAOMD1f9BUkzrn_KZCmyajjepqLQWHkIVuZYsuQuyxGYc130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755570.RAOMD1f9BUkzrn_KZCmyajjepqLQWHkIVuZYsuQuyxGYc130_provenance.
- NP491286.RAT6rR3HkokhGI7xbEpK8C-zOpYjO2LpXz8d8bpn07Yxk130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491286.RAT6rR3HkokhGI7xbEpK8C-zOpYjO2LpXz8d8bpn07Yxk130_provenance.
- NP491289.RAPDfuQMPW3H01oU2qFOmK8cNbZ-8PcqgmhdfMVvcP-Z4130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491289.RAPDfuQMPW3H01oU2qFOmK8cNbZ-8PcqgmhdfMVvcP-Z4130_provenance.
- NP755593.RApWd6c0arEblLL23Z9CePGVtcS7XyPSctbLV0oQIhKGQ130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755593.RApWd6c0arEblLL23Z9CePGVtcS7XyPSctbLV0oQIhKGQ130_provenance.
- NP476172.RANQHLLIA_zSF8msLCrnU8VfZOk9biHYNHFcajSHdEJek130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476172.RANQHLLIA_zSF8msLCrnU8VfZOk9biHYNHFcajSHdEJek130_provenance.
- NP952662.RApf6qHMLtQUdD0ps5Cle5T8-_ZdE2Tr-1Hty0G1-ydKQ130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952662.RApf6qHMLtQUdD0ps5Cle5T8-_ZdE2Tr-1Hty0G1-ydKQ130_provenance.
- NP491283.RAmVbNGGWukKfuevCwDknOKKOzTA4MpPlui5kwUjEJP7M130_assertion description "[The frequency of p73 mutation is low in hematologic malignancies as well as solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP491283.RAmVbNGGWukKfuevCwDknOKKOzTA4MpPlui5kwUjEJP7M130_provenance.